Mdica Sur (Mexico) Performance
| MEDICAB Stock | MXN 35.00 0.00 0.00% |
Mdica Sur has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.19, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Mdica Sur's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mdica Sur is expected to be smaller as well. Mdica Sur SAB right now secures a risk of 1.15%. Please verify Mdica Sur SAB potential upside, rate of daily change, and the relationship between the treynor ratio and expected short fall , to decide if Mdica Sur SAB will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mdica Sur SAB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong forward indicators, Mdica Sur is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 572.8 M | |
| Total Cashflows From Investing Activities | 2.6 B |
Mdica |
Mdica Sur Relative Risk vs. Return Landscape
If you would invest 3,423 in Mdica Sur SAB on December 23, 2024 and sell it today you would earn a total of 77.00 from holding Mdica Sur SAB or generate 2.25% return on investment over 90 days. Mdica Sur SAB is generating 0.0429% of daily returns and assumes 1.1482% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Mdica, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Mdica Sur Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mdica Sur's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mdica Sur SAB, and traders can use it to determine the average amount a Mdica Sur's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0374
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MEDICAB |
Estimated Market Risk
| 1.15 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Mdica Sur is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mdica Sur by adding it to a well-diversified portfolio.
Mdica Sur Fundamentals Growth
Mdica Stock prices reflect investors' perceptions of the future prospects and financial health of Mdica Sur, and Mdica Sur fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mdica Stock performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0682 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.62 B | |||
| Shares Outstanding | 123.28 M | |||
| Price To Earning | 6.81 X | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 3.91 B | |||
| EBITDA | 995.97 M | |||
| Cash And Equivalents | 933.95 M | |||
| Cash Per Share | 7.70 X | |||
| Total Debt | 991.93 M | |||
| Debt To Equity | 0.30 % | |||
| Book Value Per Share | 22.57 X | |||
| Cash Flow From Operations | 821.32 M | |||
| Earnings Per Share | 3.05 X | |||
| Total Asset | 6.98 B | |||
About Mdica Sur Performance
By analyzing Mdica Sur's fundamental ratios, stakeholders can gain valuable insights into Mdica Sur's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mdica Sur has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mdica Sur has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Mdica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. MEDICA SUR operates under Medical Care Facilities classification in Mexico and is traded on Mexico Stock Exchange. It employs 3573 people.Things to note about Mdica Sur SAB performance evaluation
Checking the ongoing alerts about Mdica Sur for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mdica Sur SAB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 50.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Mdica Sur's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mdica Sur's stock is overvalued or undervalued compared to its peers.
- Examining Mdica Sur's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mdica Sur's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mdica Sur's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mdica Sur's stock. These opinions can provide insight into Mdica Sur's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mdica Stock analysis
When running Mdica Sur's price analysis, check to measure Mdica Sur's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mdica Sur is operating at the current time. Most of Mdica Sur's value examination focuses on studying past and present price action to predict the probability of Mdica Sur's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mdica Sur's price. Additionally, you may evaluate how the addition of Mdica Sur to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |